Treatment Registry

Company

Bon Health

Bon Health publishes compounded semaglutide, compounded tirzepatide, brand tirzepatide and brand semaglutide, from $230 to $1,319 a month.

  • 4 programs
  • 4 molecules
  • 8 readings

Read from bonhealth.io on September 3, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to Bon Health

Visit Bon Health

We earn nothing from this link. Bon Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

What it costs

first month, including the required fees on record · Monthly

first month, including the required fees on record · Monthly

first month, including the required fees on record · Mounjaro

first month, including the required fees on record · Ozempic

Terms

MembershipNone. “Bon Health charges no membership fee - the per-month price for your chosen commitment tier is what you pay, billed monthly or quarterly depending on the plan you select.”
StatesNot disclosed

Not yet checked: pharmacy and consultation fee.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderPer month
at its shortest term
Link
TR-0551Bon Health$230
Monthly
Record
TR-0550Bon Health$330
Monthly
Record
TR-0553Bon Health$1,269
Mounjaro
Record
TR-0552Bon Health$1,319
Ozempic
Record

Notes

Recorded against this company rather than one program.

September 2, 2026

  1. 1. Bon Health is explicit that its per-drug prices already include everything: '$0 Membership fee. Your medication price is your final price.' and '† Prices reflect medication only. No membership fee. Cancel anytime.' The compounded-tirzepatide product page is where the four commitment tiers (monthly/3-month/6-month/annual) are shown in full; the compounded-semaglutide tab only exposed one static monthly price ($230/mo) in this tool's output, its own tiered breakdown was not recoverable. Brand-name product tiles (Wegovy/Ozempic/Zepbound/Mounjaro, listed as 'Compounded name-brand GLP-1 therapies' despite being FDA-approved brand products) give real cash prices; No form (vial/pen) is stated for any product on this page, compounded or brand, so all entries use not-disclosed; no explicit sync/async statement was found either.

Before you act

Cite this

Treatment Registry. (2026). Bon Health: recorded programs and prices. Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/bon-health